3[1]Ellestad MH, Olson WHi. Use of intravenously given ganglionic blocking agents for acute pulmonary edema [J]. JAMA, 1956, 161: 49-53.
4[2]Cohn JN, Archibald DG, Ziesche S, et al. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study [J]. N Engl J Med, 1986, 314:1547-1552
5[3]Packer M, Carver JR, Rodeheffer RJ, et al. Effect of oral milrinone on nortality in severe chronic heart failure. The PROMISE Study Research Group [J]. N Engl J Med, 1991, 325: 1468-1475.
6[4]Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. The SOLVD Investigators [J]. N Engl J Med, 1991, 325: 293-302.
7[5]The CONSENSUS Trial Study Group. Effects of enalapril on mortality in severs congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Stludy (CONSENSUS) [J]. N Engl J Med, 1987, 316: 1249-1345.
8[6]Cohn JN, Johnson G, Ziesche S, et al. A comparison of enalapril with hydrala-ziue-isosorbide dinitrate in the treatment of chronic congestive heart failure [J].N Engl J Med, 1991, 325: 303-310.
9[7]Waagstein F, Bristow MR, Swedberg K, et al. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group [J]. Lancet, 1993, 342: 1441-1446.
10[8]Di Lenarda A, De Maria R, Gavazzi A, et al. Long-term survival effect of metoprolol in dilated cardiomyopathy. The SPIC (Italian Multicentre Cardiomyopathy Study) Group [J]. Heart, 1998, 79: 337-344.
